摘要
转录因子阴阳-1(YY1)是一种调节基因转录和蛋白修饰的多功能的蛋白。最近的研究揭示了YY1在肿瘤形成中的增殖作用。YY1过度表达总是存在于人类各种恶性肿瘤中,且表达水平与多种肿瘤的预后不良相关。在此综述中,我们集中讨论信号通路和调节蛋白,其中YY1调节促进肿瘤细胞生长、繁殖、迁移和转移。我们还讨论了在癌症背景下调节YY1表达和作用的信号和分子。基于在肿瘤细胞中的表达特征和调节活动,YY1用作多种癌症的生物标记具有巨大潜力,且临床可用作治疗靶点来阻碍癌症的进展或者提高癌细胞对抗癌药的敏感性。
关键词: 基因表达,基因,蛋白质相互作用,靶向治疗,肿瘤形成,转录因子阴阳-1。
图形摘要
Current Cancer Drug Targets
Title:The Role of YY1 in Oncogenesis and Its Potential as a Drug Target in Cancer Therapies
Volume: 15 Issue: 2
Author(s): Jinming Shi, Aixin Hao, Qiang Zhang and Guangchao Sui
Affiliation:
关键词: 基因表达,基因,蛋白质相互作用,靶向治疗,肿瘤形成,转录因子阴阳-1。
摘要: Yin Yang 1 (YY1) is a multifunctional protein regulating both gene transcription and protein modifications. Recent studies reveal a proliferative role of YY1 in oncogenesis. Consistently, YY1 overexpression has been observed in various human malignancies and its levels correlate with poor prognoses of many types of cancers. In this review, we focus on the signaling pathways and regulatory proteins that YY1 modulates to promote tumor cell growth, proliferation, migration and metastasis. We also discuss the signals and molecules that regulate YY1 expression and function in cancer-related context. Based on the expression feature and regulatory activities in tumor cells, YY1 possesses a great potential as a biomarker for many cancers and can serve as a therapeutic target clinically to impede cancer development and progression or sensitize cancer cells to anticancer drugs.
Export Options
About this article
Cite this article as:
Jinming Shi, Aixin Hao, Qiang Zhang and Guangchao Sui , The Role of YY1 in Oncogenesis and Its Potential as a Drug Target in Cancer Therapies, Current Cancer Drug Targets 2015; 15 (2) . https://dx.doi.org/10.2174/1568009615666150131124200
DOI https://dx.doi.org/10.2174/1568009615666150131124200 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacokinetic Mechanisms for Reduced Toxicity of Irinotecan by Coadministered Thalidomide
Current Drug Metabolism Detection of Early Cancer: Genetics or Immunology? Serum Autoantibody Profiles as Markers of Malignancy
Anti-Cancer Agents in Medicinal Chemistry Near-infrared Light Activatable Multimodal Gold Nanostructures Platform: An Emerging Paradigm for Cancer Therapy
Current Cancer Drug Targets Targeted Drug Delivery Via Human Epidermal Growth Factor Receptor for Sustained Release of Allyl Isothiocyanate
Current Topics in Medicinal Chemistry Anti-Cancer Potential of Some Commonly Used Drugs
Current Pharmaceutical Design Cancer Therapeutics-Related Cardiovascular Complications. Mechanisms, Diagnosis and Treatment
Current Pharmaceutical Design Management of Locally Advanced Cancer Cervix an Indian Perspective
Reviews on Recent Clinical Trials Engineering Nanomedicines to Overcome Multidrug Resistance in Cancer Therapy
Current Medicinal Chemistry Current Understanding of HSP90 as a Novel Therapeutic Target: An Emerging Approach for the Treatment of Cancer
Current Pharmaceutical Design Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies
Current Pharmacogenomics and Personalized Medicine A Review of Pharmacological Treatment Options for Lung Cancer: Emphasis on Novel Nanotherapeutics and Associated Toxicity
Current Drug Targets Unique Biology of Mcl-1: Therapeutic Opportunities in Cancer
Current Molecular Medicine Inhibitors of ER Aminopeptidase 1 and 2: From Design to Clinical Application
Current Medicinal Chemistry Differential Effects of Doxazosin on Renin-Angiotensin-System- Regulating Aminopeptidase Activities in Neuroblastoma and Glioma Tumoral Cells
CNS & Neurological Disorders - Drug Targets CXCR4 and Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry Quinone-Based Drugs: An Important Class of Molecules in Medicinal Chemistry
Medicinal Chemistry Characterization and Inhibition of the Recently Discovered Carbonic Anhydrase Isoforms CA XIII, XIV and XV
Current Topics in Medicinal Chemistry MicroRNAs in Breast Cancer: One More Turn in Regulation
Current Drug Targets Electrical Impedance Scanning - A New Diagnostic Tool in Cancer Detection: Current Status and Recent Developments
Current Medical Imaging Exploiting Protein Phosphatase Inhibitors Based on Cantharidin Analogues for Cancer Drug Discovery
Mini-Reviews in Medicinal Chemistry